Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | BMC Bioinformatics

Figure 4

From: Analysis and verification of the HMGB1 signaling pathway

Figure 4

HMGB1 and AKT sensitivity study. Overexpression of HMGB1 (A-B, D-E) leads to the increase of oncoprotein E2F and DNA replication proteins CyclinD/E, and to the decrease of p53. Overexpression of AKT (C, F) activated by HMGB1 increases the expression level of MDM2 p and represses p53, using ODE (A-C) and SSA (D-F) simulations.

Back to article page